Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Immunotargets and Therapy|June 6, 2017
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetesArata Itoh, William M RidgwayJournal of Immunology (Baltimore, Md. : 1950)|September 16, 2021
Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic PeptidesMeng Li, Arata Itoh, Jingchao Xi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2017
CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD MiceMatthew H Forsberg, Ashley E Ciecko, Kyle J Bednar, et al.Immunologic Research|March 6, 2007
Dissecting genetic control of autoimmunity in NOD congenic miceWilliam M RidgwayFrontiers in Immunology|December 3, 2019
Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell AnergyArata Itoh, Lorenzo Ortiz, Kritika Kachapati, et al.The Keio Journal of Medicine|October 21, 2005
A modular theory of autoimmunityJunichiro Irie, William M RidgwayHepatology (Baltimore, Md.)|January 19, 2021
Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune CholangitisArata Itoh, David Adams, Wenting Huang, et al.Journal of Diabetes and Its Complications|July 8, 2017
GLP-1 receptor agonist, liraglutide, ameliorates hepatosteatosis induced by anti-CD3 antibody in female miceArata Itoh, Junichiro Irie, Hirotsune Tagawa, et al.Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
The non-obese diabetic (NOD) mouse as a model of human type 1 diabetesKritika Kachapati, David Adams, Kyle Bednar, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic backgroundSyuichi Koarada, Yuehong Wu, Grace Olshansky, et al.Pageof 10